6.65
+0.08(+1.22%)
Currency In USD
| Previous Close | 6.57 |
| Open | 6.59 |
| Day High | 6.68 |
| Day Low | 6.52 |
| 52-Week High | 7.99 |
| 52-Week Low | 3.68 |
| Volume | 208,723 |
| Average Volume | 208,050 |
| Market Cap | 246.22M |
| PE | -11.87 |
| EPS | -0.56 |
| Moving Average 50 Days | 6.1 |
| Moving Average 200 Days | 5.85 |
| Change | 0.08 |
If you invested $1000 in Lifecore Biomedical, Inc. (LFCR) 10 years ago, it would be worth $471.63 as of March 20, 2025 at a share price of $6.65. Whereas If you bought $1000 worth of Lifecore Biomedical, Inc. (LFCR) shares 5 years ago, it would be worth $790.73 as of March 20, 2025 at a share price of $6.65.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
GlobeNewswire Inc.
Mar 17, 2025 11:00 AM GMT
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out Tech Transfer and Analytical Method Activities, including Filling of Pilot Batch CHASKA, M
Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences
GlobeNewswire Inc.
Feb 26, 2025 9:05 PM GMT
CHASKA, Minn., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple u
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference
GlobeNewswire Inc.
Feb 03, 2025 12:00 PM GMT
CHASKA, Minn., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 2025 B